SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026867
Filing Date
2023-09-27
Accepted
2023-09-27 11:45:15
Documents
13
Period of Report
2023-09-27
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230927_8k.htm   iXBRL 8-K 34805
  Complete submission text file 0001437749-23-026867.txt   184330

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230927.xsd EX-101.SCH 3891
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230927_def.xml EX-101.DEF 13443
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230927_lab.xml EX-101.LAB 17670
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230927_pre.xml EX-101.PRE 13420
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230927_8k_htm.xml XML 4407
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231283399
SIC: 2836 Biological Products, (No Diagnostic Substances)